Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer - British Journal of Cancer

• 16 November 2011

  This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication

• Abels RI, Larholt KM, Krantz KD, Bryant EC (1991) Recombinant human erythropoietin (r-HuEPO) for the treatment of anemia of cancer. In: Blood Cell Growth Factors: Their Present and Future use in Hematology and Oncology. Proceedings of the Beijing Symposium, Murphy MJ Jr (ed). AlphaMed Press: Dayton, OH 121–142

  Google Scholar 

• Cella D (1997) The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 34: 13–19

  CAS  Google Scholar 

• Cooke K, Stoney G, Pistillo J, Del Castillo J, Molineux G and Coccia MA (2000) Anemia of chronic disease (ACD) in a rodent model is similar to human ACD and can be alleviated by ARANESP™ treatment. Blood 96: 8a (abstract 20)

  Google Scholar 

• Egrie JC, Dwyer E, Lykos M, Hitz A and Browne JK (1997) Novel erythropoiesis stimulating protein (NESP) has a longer serum half-life and greater in vivo biological activity than recombinant human erythropoietin (rHuEPO). Blood 90: 56a–57a (abstract 243)

  Google Scholar 

• Glaspy J, Colowick AB and Heatherington A (2000) Novel erythropoiesis stimulating protein (NESP) exhibits a prolonged serum half-life (T1/2) in oncology patients (pts). Proc Am Soc Clin Oncol 19: 54a (abstract 210)

  Google Scholar 

• Henry DH and Abels RI (1994) Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studies. Semin Oncol 21: 21–28

  CAS  PubMed  Google Scholar 

• Jelkmann W (1998) Proinflammatory cytokines lowering erythropoietin production. J Interferon Cytokine Res 18: 555–559

  Article  CAS  Google Scholar 

• Ludwig H and Fritz E (1998) Anemia in cancer patients. Semin Oncol 25: 2–6

  CAS  Google Scholar 

• Ludwig H, Fritz E, Leitgeb C, Pecherstorfer M, Samonigg H and Schuster J (1994) Prediction of response to erythropoietin treatment in chronic anemia of cancer. Blood 84: 1056–1063

  CAS  PubMed  Google Scholar 

• Ludwig H, Sundal E, Pecherstorfer M, Leitgeb C, Bauernhofer T, Beinhauer A, Samonigg H, Kappeler AW and Fritz E (1995) Recombinant human erythropoietin for the correction of cancer associated anemia with and without cytotoxic chemotherapy. Cancer 76: 2319–2329

  Article  CAS  Google Scholar 

• Macdougall IC, Gray SJ, Elston O, Breen C, Jenkins B, Browne J and Egrie J (1999) Pharmacokinetics of novel erythropoiesis stimulating protein compared with Epoetin alfa in dialysis patients. J Am Soc Nephrol 10: 2392–2395

  CAS  PubMed  Google Scholar 

• Miller CB, Jones RJ, Piantadosi S, Abeloff MD and Spivak JL (1990) Decreased erythropoietin response in patients with anemia of cancer. N Engl J Med 322: 1689–1692

  Article  CAS  Google Scholar 

• Ozguroglu M, Arun B, Demir G, Demirelli F, Mandel NM, Buyukunal E, Serdengecti S and Berkarda B (2000) Serum erythropoietin level in anemic cancer patients. Med Oncol 17: 29–34

  Article  CAS  Google Scholar 

Download references

Authors and Affiliations

1. South Carolina Oncology Associates, 1301 Taylor, Suite IA, Columbia, SC 29201, USA

   R E Smith Jr

2. William Beaumont Hospital, 3577 West 13 Mile Road, Suite 40, Royal Oak, MI 48073, USA

   I A Jaiyesimi

3. Southwest Oncology Associates, 443 Heymann Blvd, Suite A, Lafayette, LA 70503, USA

   L A Meza

4. Pacific Shores Medical Group Inc, 1043 Elm Ave, Suite 104, Long Beach, CA 90813-3244, USA

   N S Tchekmedyian

5. Cancer Care Associates Medical Group, 514 North Prospect St, Redondo Beach, CA 90277-3026, USA

   D Chan

6. Memorial Clinic Research Center, 520 Lilly Road, NE Building 3, Olympia, WA 98506, USA

   H Griffith

7. Pacific Clinical Research, 1260 15th Street, Suite 1200, Santa Monica, CA 90404, USA

   S Brosman

8. The Cleveland Clinic Foundation, Desk S33, 9500 Euclid Avenue, Cleveland, OH 44195, USA

   R Bukowski

9. Urology Associates, 7500 Hanover Parkway, Suite 206, Greenbelt, MD 20770, USA

   M Murdoch

10. Kaiser Permanente Northwest Division, 3600 North Interstate, Portland, OR 97227, USA

    M Rarick

11. Scripps Clinic, 10666 North Torrey Pines Road, La Jolla, CA 92037, USA

    A Saven

12. Amgen Inc, One Amgen Center Drive, Thousand Oaks, CA 91320-1799, USA

    A B Colowick

13. Amgen Inc, One Amgen Center Drive, M/S 24-1-C, Thousand Oaks, CA 91320-1799, USA

    A Fleishman

14. Amgen Inc, One Amgen Center Drive; M/S 24-1-C, Thousand Oaks, CA 91320-1799, USA

    U Gayko

15. UCLA School of Medicine, 200 Medical Plaza, Suite 120, Los Angeles, CA 90024, USA

    J Glaspy

From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/

Reprints and permissions

Cite this article

Smith, R., Jaiyesimi, I., Meza, L. et al. Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer. Br J Cancer 84 (Suppl 1), 24–30 (2001). https://doi.org/10.1054/bjoc.2001.1749

Download citation

• Published: 03 April 2001

• Issue Date: 01 April 2001

• DOI: https://doi.org/10.1054/bjoc.2001.1749

Keywords